2. Academic Validation
  3. Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat

Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat

  • J Allergy Clin Immunol. 2016 Sep;138(3):934-936.e5. doi: 10.1016/j.jaci.2016.03.043.
Emel Aygören-Pürsün 1,  Markus Magerl 2,  Jochen Graff 3,  Inmaculada Martinez-Saguer 4,  Wolfhart Kreuz 4,  Hilary Longhurst 5,  Iman Nasr 5,  Murat Bas 6,  Ulrich Straßen 6,  Lei Fang 7,  Melanie Cornpropst 8,  Sylvia Dobo 8,  Phil Collis 8,  William P Sheridan 8,  Marcus Maurer 9
Affiliations

Affiliations

  • 1 Centre of Pediatrics III, Department of Hematology, Oncology and Hemostasis, Comprehensive Care Centre for Thrombosis and Hemostasis, Johann Wolfgang Goethe University Hospital, Frankfurt am Main, Germany.
  • 2 Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • 3 Institute of Clinical Pharmacology, Johann Wolfgang Goethe-University, Frankfurt, Germany.
  • 4 Haemophilia Centre Rhine Main, Frankfurt-Mörfelden, Germany.
  • 5 Department of Immunology, Barts Health NHS Trust, London, United Kingdom.
  • 6 HNO-Klinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
  • 7 Pharstat Inc, Durham, NC.
  • 8 BioCryst Pharmaceuticals Inc, Durham, NC.
  • 9 Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: [email protected].
PMID: 27302552 DOI: 10.1016/j.jaci.2016.03.043
Figures
Products